Page 1 of Clinical Trials for ( Molecular Insight Pharmaceuticals AND Inc. ) [SPONSOR-COLLABORATORS], 16 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome
Last Updated: June 4, 2009
Condition(s): Acute Coronary Syndrome
2
Recruiting
Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection
Last Updated: April 4, 2012
Condition(s): Prostate Cancer
3
Active, not recruiting
A Study Evaluating Ultratrace Iobenguane I 131(MIBG)in Patients With Malignant Pheochromocytoma/Paraganglioma
Last Updated: June 6, 2011
Condition(s): Pheochromocytoma; Paraganglioma
4
Terminated
Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma
Last Updated: October 7, 2011
Condition(s): Metastatic Melanoma
5
Completed
Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents
Last Updated: October 7, 2011
Condition(s): Prostate Cancer
6
Recruiting
Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma
Last Updated: June 1, 2009
Condition(s): Pheochromocytoma; Paraganglioma
7
Completed
Study to Evaluate the Efficacy and Safety of 90Y-SMT487 in Subjects With Symptomatic Malignant Carcinoid Tumors
Last Updated: June 12, 2008
Condition(s): Malignant Carcinoid Tumor
8
Completed
ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid
Last Updated: October 7, 2011
Condition(s): Pheochromocytoma; Paraganglioma; Carcinoid
9
Completed
A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer
Last Updated: October 7, 2011
Condition(s): Prostate Cancer
10
Active, not recruiting
Phase 1-2 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma
Last Updated: June 4, 2009
Condition(s): Pheochromocytoma; Paraganglioma
11
Active, not recruiting
A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy Volunteers
Last Updated: April 3, 2012
Condition(s): Prostate Cancer
12
Terminated
Efficacy and Safety of Ultratrace™ Iobenguane I 131 in Neuroblastoma
Last Updated: October 7, 2011
Condition(s): Neuroblastoma
13
Terminated
A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy
Last Updated: October 7, 2011
Condition(s): Prostate Cancer
14
Completed
Accuracy of Radiolabeled Fatty Acid Analog, BMIPP, in the Late Detection of Decreased Blood Flow to the Heart
Last Updated: March 25, 2009
Condition(s): Coronary Artery Disease; Acute Coronary Syndrome; Ischemic Heart Disease
15
Active, not recruiting
N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma
Last Updated: April 26, 2012
Condition(s): Neuroblastoma
16
Active, not recruiting
90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)
Last Updated: January 12, 2010
Condition(s): Neuroblastoma; Neuroendocrine Tumor

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Molecular+Insight+Pharmaceuticals%2C+Inc.

Page 1 of Clinical Trials for ( Molecular Insight Pharmaceuticals AND Inc. ) [SPONSOR-COLLABORATORS], 16 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About